<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
	"http://www.w3.org/TR/1998/REC-html40-19980424/loose.dtd">
<html>
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8">
<style type="text/css">
 table.main {}
 tr.row {}
 td.cell {}
 div.block {}
 div.paragraph {}
 .font0 { font:7pt Arial, sans-serif; }
 .font1 { font:8pt Arial, sans-serif; }
 .font2 { font:16pt Arial, sans-serif; }
 .font3 { font:10pt Times New Roman, serif; }
 .font4 { font:14pt Times New Roman, serif; }

</style>
</head>
<body>
<p><span class="font4">JPMorgan</span></p>
<p><span class="font0" style="font-weight:bold;">Asia Pacific Equity Research</span></p>
<p><span class="font0" style="font-weight:bold;">07 September 2016</span></p>
<p><span class="font0" style="font-weight:bold;">Isabella Y. Zhao, CFA</span></p>
<p><span class="font0" style="font-weight:bold;">(852) 2800-8534</span></p>
<p><a href="mailto:isabella.zhao@jpmorgan.com"><span class="font0" style="font-weight:bold;">isabella.zhao@jpmorgan.com</span></a></p><a name="caption1"></a>
<h5><a name="bookmark0"></a><span class="font2"><a name="bookmark1"></a>Financial Analysis</span></h5>
<p><span class="font1" style="font-weight:bold;">Revenue forecast</span></p>
<p><span class="font3">Excluding the effect of disposal of four companies and new acquisition of Erye pharmaceutical, Fosun Pharma’s sales increased by 15% in 2015. We expect acceleration in sales growth of 16.6%, 16.8% and 16.3% in 2016-2018.</span></p>
<p><span class="font3">In 1H16, Fosun's revenue increased by 17.15% as compared to 1H15 to RMB6,937mn. Among its segments, Pharmaceutical manufacturing increased by 20% organically, the Diagnostics and medical devices increased by 14% and Healthcare services increased by 12%.</span></p>
<p><span class="font3">As of 1H16, the highest proportion (69.7%) of this revenue came from Pharmaceutical Manufacturing. With continued investment in R&amp;D and 172 pipeline products, we expect revenue of this segment to grow by 14% in each year during 2016-18. The other sectors: Diagnostics products &amp;&nbsp;medical devices and Healthcare sendees are expected to increase by 25% and 20% respectively in each year during 2016-18, per our estimates.</span></p>
<p><span class="font0" style="font-weight:bold;">19</span></p>
</body>
</html>